Detecting and targeting NTRK gene fusions in cholangiocarcinoma: news and perspectives

Cholangiocarcinomas (CCAs) are rare and aggressive tumors accounting for less than 1% of all malignancies worldwide and approximately the 10–15% of all primary liver cancers [1]. Unfortunately, adv...